Imberti, Jacopo Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.287
AS - Asia 6.509
EU - Europa 3.246
SA - Sud America 984
OC - Oceania 258
Continente sconosciuto - Info sul continente non disponibili 168
AF - Africa 145
Totale 20.597
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.890
SG - Singapore 2.076
CN - Cina 1.926
IT - Italia 1.208
BR - Brasile 760
HK - Hong Kong 731
VN - Vietnam 618
GB - Regno Unito 397
FI - Finlandia 305
KR - Corea 299
DE - Germania 279
BD - Bangladesh 265
AU - Australia 256
RU - Federazione Russa 237
SE - Svezia 229
CA - Canada 178
FR - Francia 149
ID - Indonesia 102
IN - India 96
AR - Argentina 81
MX - Messico 77
NL - Olanda 77
JP - Giappone 44
TR - Turchia 44
LT - Lituania 43
AE - Emirati Arabi Uniti 40
IQ - Iraq 40
PL - Polonia 39
ZA - Sudafrica 38
UA - Ucraina 37
AT - Austria 35
ES - Italia 35
PK - Pakistan 35
CO - Colombia 34
EC - Ecuador 33
BG - Bulgaria 31
CR - Costa Rica 24
VE - Venezuela 23
UZ - Uzbekistan 22
IE - Irlanda 21
IL - Israele 21
MA - Marocco 21
CL - Cile 20
EG - Egitto 19
JM - Giamaica 17
MY - Malesia 17
TH - Thailandia 17
KE - Kenya 16
RS - Serbia 16
SC - Seychelles 16
HN - Honduras 14
SA - Arabia Saudita 14
TT - Trinidad e Tobago 14
AZ - Azerbaigian 13
BE - Belgio 13
CZ - Repubblica Ceca 13
GT - Guatemala 13
PR - Porto Rico 13
RO - Romania 13
SV - El Salvador 13
DZ - Algeria 11
PY - Paraguay 11
TW - Taiwan 11
OM - Oman 10
TN - Tunisia 10
BO - Bolivia 9
JO - Giordania 9
KZ - Kazakistan 8
NI - Nicaragua 8
PH - Filippine 8
PT - Portogallo 8
EE - Estonia 7
HU - Ungheria 7
NP - Nepal 7
PE - Perù 7
AL - Albania 6
CH - Svizzera 6
CU - Cuba 6
CW - ???statistics.table.value.countryCode.CW??? 6
GE - Georgia 6
DO - Repubblica Dominicana 5
IR - Iran 5
UY - Uruguay 5
AM - Armenia 4
BY - Bielorussia 4
GP - Guadalupe 4
HR - Croazia 4
SK - Slovacchia (Repubblica Slovacca) 4
CY - Cipro 3
KG - Kirghizistan 3
LK - Sri Lanka 3
LU - Lussemburgo 3
LV - Lettonia 3
MD - Moldavia 3
NG - Nigeria 3
NO - Norvegia 3
PS - Palestinian Territory 3
QA - Qatar 3
SN - Senegal 3
BA - Bosnia-Erzegovina 2
Totale 20.398
Salva come PNG Salva come JPEG
Città #
Ashburn 1.431
Singapore 1.289
Santa Clara 1.039
Hefei 931
San Jose 896
Hong Kong 723
Council Bluffs 441
Seoul 299
Helsinki 246
Beijing 242
Fairfield 240
Los Angeles 239
New York 227
Chandler 220
London 216
Ho Chi Minh City 203
Nyköping 180
The Dalles 169
Perth 167
Dallas 144
Chicago 135
Hanoi 135
Milan 117
Houston 107
Bologna 103
Seattle 99
Woodbridge 97
Buffalo 92
Munich 91
Rome 90
Wilmington 81
São Paulo 78
Cambridge 72
Lauterbourg 72
Shanghai 70
Jakarta 69
Modena 65
North Bergen 57
Kent 52
Moscow 51
San Diego 50
Salt Lake City 49
Montreal 45
Princeton 44
Orem 42
Sydney 42
Toronto 41
Mexico City 40
Boardman 39
Lappeenranta 39
Atlanta 37
Frankfurt am Main 37
Denver 36
Tokyo 36
Columbus 35
Ann Arbor 34
Da Nang 33
Phoenix 33
Haiphong 29
Sofia 29
Brooklyn 28
Warsaw 27
San Francisco 26
Turin 26
Belmont 25
Nuremberg 25
Schiffdorf 25
Southend 25
Johannesburg 24
Amsterdam 23
Redondo Beach 23
Lakewood 22
Memphis 22
Naples 22
Dublin 20
Miami 20
San José 20
Tashkent 20
Boston 19
Guangzhou 19
Rio de Janeiro 19
Turku 19
Vienna 19
Parma 18
Stockholm 18
Tampa 18
Düsseldorf 17
Vilnius 17
Baghdad 16
Brasília 16
Lansdowne 16
Portsmouth 16
Washington 16
Belo Horizonte 15
Campinas 15
Charlotte 15
Chennai 15
Hải Dương 15
Kilburn 15
Newark 15
Totale 12.836
Salva come PNG Salva come JPEG
Nome #
Atrial Fibrillation in the Setting of Acute Pneumonia: Not a Secondary Arrhythmia 522
Drug management of atrial fibrillation in light of guidelines and current evidence: an Italian Survey on behalf of Italian Association of Arrhythmology and Cardiac Pacing 382
Impact of COVID-19 pandemic on the clinical activities related to arrhythmias and electrophysiology in Italy: results of a survey promoted by AIAC (Italian Association of Arrhythmology and Cardiac Pacing) 358
Percutaneous pericardiocentesis for pericardial effusion: predictors of mortality and outcomes 343
Device-detected atrial high rate episodes and the risk of stroke/thrombo-embolism and atrial fibrillation incidence: a systematic review and meta-analysis 339
The 2024 ESC guidelines on atrial fibrillation: essential updates for everyday clinical practice 316
Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients 302
DIGItal Health Literacy after COVID-19 Outbreak among Frail and Non-Frail Cardiology Patients: The DIGI-COVID Study 299
2022 ESC Guidelines for the management of ventricular arrhythmias and sudden cardiac death: an important focus on a multidisciplinary approach to a tailored diagnostic and therapeutic work-up|Linee guida europee 2022 su aritmie ventricolari e morte cardiaca improvvisa: un importante impulso a un impegno multidisciplinare in campo diagnostico e terapeutico per un’accurata personalizzazione dell’approccio clinico 288
Cardioversion of recent-onset atrial fibrillation: current evidence, practical considerations, and controversies in a complex clinical scenario 277
Single-lead VDD pacing: a literature review on short-term and long-term performance 267
Comparative analysis of level of evidence and class of recommendation for 50 clinical practice guidelines released by the European Society of Cardiology from 2011 to 2022 266
Long-term outcomes of postoperative atrial fibrillation following non cardiac surgery: A systematic review and metanalysis 265
Atrial cardiomyopathy: An entity of emerging interest in the clinical setting 252
Atrial fibrillation burden: Stepping beyond the categorical characterization 244
Red cell distribution width: a routinely available biomarker with important clinical implications in patients with atrial fibrillation 244
Progression of Atrial Fibrillation after Cryoablation 240
Remote monitoring and telemedicine in heart failure: implementation and benefits 238
Detection of subclinical atrial fibrillation with cardiac implanted electronic devices: What decision making on anticoagulation after the NOAH and ARTESiA trials? 229
A systematic review and meta-analysis on oncological radiotherapy in patients with a cardiac implantable electronic device: Prevalence and predictors of device malfunction in 3121 patients 227
Short and long-term outcomes after cardiac surgery in Jehovah's Witnesses patients: a case-control study 225
Radiotherapy-induced malfunctions of cardiac implantable electronic devices in cancer patients 223
What do we do about atrial high rate episodes? 220
Atrial high-rate episodes: clinical significance, prognostic impact and clinical management 219
Clinical significance and prognostic value of right bundle branch block in permanent pacemaker patients 217
Low Occurrence of Infections and Death in a Real-World Cohort of Patients with Cardiac Implantable Electronic Devices 214
Atrial fibrillation and remote monitoring through cardiac implantable electronic devices in heart failure patients 213
Female sex and stroke in atrial fibrillation: an intriguing relationship 204
Adherence to the “Atrial fibrillation Better Care” (ABC) pathway in patients with atrial fibrillation and cancer: A report from the ESC-EHRA EURObservational Research Programme in atrial fibrillation (EORP-AF) General Long-Term Registry 201
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study 201
Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients 198
Clinical Factors Associated with Atrial Fibrillation Detection on Single-Time Point Screening Using a Hand-Held Single-Lead ECG Device 198
Cardiac Surgery in Jehovah's Witnesses Patients and Association With Peri-Operative Outcomes: A Systematic Review and Meta-Analysis 197
Cardiovascular Reasons for Access to a Tertiary Oncological Emergency Service: The CARILLON Study 196
Cardiac resynchronization therapy (CRT) nonresponders in the contemporary era: A state-of-the-art review 196
Catheter ablation as first-line treatment for paroxysmal atrial fibrillation: A systematic review and meta-analysis 196
Managing atrial fibrillation: the need for an individualized approach even in the emergency department 192
Performance of HAS-BLED and DOAC scores to predict major bleeding events in atrial fibrillation patients treated with direct oral anticoagulants: A report from a prospective European observational registry 191
Features of Clinical Complexity in European Patients With Atrial Fibrillation: A Report From a European Observational Prospective AF Registry 190
Atrial fibrillation in pneumonia: what clinical implications at long-term? 190
Atrial cardiomyopathy: a derangement in atrial volumes, geometry, function, and pathology with important clinical implications 190
Anticoagulation to prevent ischemic stroke in patients with atrial fibrillation: a complex scenario including underdiagnosis, undertreatment or underdosing of oral anticoagulants 189
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target 183
Comparing atrial fibrillation guidelines: Focus on stroke prevention, bleeding risk assessment and oral anticoagulant recommendations 183
Systematic review and meta-Analysis on the impact on outcomes of device algorithms for minimizing right ventricular pacing 180
Clinical decisions for appropriate management of patients with atrial fibrillation 177
Ventricular and Atrial Remodeling after Transcatheter Edge-to-Edge Repair: A Pilot Study 176
Remote multiparametric monitoring and management of heart failure patients through cardiac implantable electronic devices 176
Quantification of Myocardial Contraction Fraction with Three-Dimensional Automated, Machine-Learning-Based Left-Heart-Chamber Metrics: Diagnostic Utility in Hypertrophic Phenotypes and Normal Ejection Fraction 173
Atrial fibrillation in vascular surgery: a systematic review and meta-analysis on prevalence, incidence and outcome implications 173
From meta-analysis to the individual patient with atrial fibrillation and coronary artery disease: the complexity of antithrombotic treatment in real-world clinical practice and the need for a tailored approach 169
Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices: Dynamic Changes in Episodes and Predictors of Incident Atrial Fibrillation 167
Implantable cardioverter defibrillators and devices for cardiac resynchronization therapy: what perspective for patients’ apps combined with remote monitoring? 167
Atrial fibrillation and HIV: a new association requiring pathophysiological and outcome studies 162
Cardiac resynchronization therapy: variations across Europe in implant rates and types of implanted devices 162
Inhibition of lysyl oxidase stimulates TGF-β signaling and metalloproteinases-2 and -9 expression and contributes to the disruption of ascending aorta in rats: protection by propylthiouracil 161
Incidence and Predictors of Infections and All-Cause Death in Patients with Cardiac Implantable Electronic Devices: The Italian Nationwide RI-AIAC Registry 161
Digital literacy as a potential barrier to implementation of cardiology tele-visits after COVID-19 pandemic: The INFO-COVID survey 157
Atrial Fibrillation Better Care Pathway Adherent Care Improves Outcomes in Chinese Patients With Atrial Fibrillation 155
Peripheral artery disease, antithrombotic treatment and outcomes in European and Asian patients with atrial fibrillation: analysis from two prospective observational registries 155
Atrial Fibrillation Ablation in Patients Recently Hospitalized for Worsening Heart Failure: Need for Individualized Decision-Making 154
Left and right atrial echocardiographic parameters and outcome in patients with atrial fibrillation 153
Driving restriction in patients with cardiac implantable electronic devices: an overview of worldwide regulations 151
The epidemiology and mortality of patients with atrial fibrillation: a complex landscape 146
Current status of reimbursement practices for remote monitoring of cardiac implantable electrical devices across Europe 146
Yield of diagnosis and risk of stroke with screening strategies for atrial fibrillation: a comprehensive review of current evidence 145
Atrial high rate episodes as a marker of atrial cardiomyopathy: In the quest of the Holy Grail. Author's reply 145
Real-World Use of ARNI Within GDMT in HFrEF Patients with and Without Atrial Fibrillation: A Retrospective Analysis of Cardiac and Renal Functions and Clinical Outcomes 145
Echocardiographic Left Ventricular Mass Assessment: Correlation between 2D-Derived Linear Dimensions and 3-Dimensional Automated, Machine Learning-Based Methods in Unselected Patients 144
A call to action: The need to apply guidelines recommendations with ABC or SOS to improve stroke prevention and cardiovascular outcomes in patients with atrial fibrillation 142
Optimal Medical Therapy for Heart Failure and Integrated Care in Patients With Atrial Fibrillation: A Report From the ESC-EHRA EORP Atrial Fibrillation Long-Term General Registry 142
Detection and management of postoperative atrial fibrillation after coronary artery bypass grafting or non-cardiac surgery: a survey by the AF-SCREEN International Collaboration 141
Patterns of comorbidities, clinical course, and impact of the ABC Pathway for Integrated Care in patients with atrial fibrillation: a report from the prospective Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) Registry 138
Performance of a multi-sensor implantable defibrillator algorithm for heart failure monitoring in the presence of atrial fibrillation 137
Clinical Profile, Arrhythmias, and Adverse Cardiac Outcomes in Emery–Dreifuss Muscular Dystrophies: A Systematic Review of the Literature 136
Therapeutic effects of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved ejection fraction: From outcome improvement to potentially favourable influences on atrial fibrillation burden, atrial fibrillation progression and atrial cardiomyopathy 135
Atrial fibrillation, comorbidities, stroke, and mortality in real‑world clinical practice 135
Access to implantable cardioverter defibrillator therapy within and across countries: the barriers still persist 134
Poor adherence to guideline-directed anticoagulation in elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry 134
Provision of care in clinical cardiac electrophysiology during and after the COVID-19 pandemic: An open challenge for health care systems 134
Quality indicators in the management of elderly Chinese patients with atrial fibrillation: a report from the Optimal Thromboprophylaxis in Elderly Chinese Patients with Atrial Fibrillation (ChiOTEAF) registry 132
Atrial fibrillation post-coronary or cardiac surgery: A transient inflammation-related event or the expression of a pre-existing arrhythmogenic atrial substrate? 132
Antiarrhythmic drugs in the era of atrial fibrillation ablation 131
4S-AF scheme and ABC pathway guided management improves outcomes in atrial fibrillation patients 125
Oral anticoagulation for atrial fibrillation and high risk of bleeding in daily practice: What clinical considerations? 125
The search for a gold standard to clinically diagnose and monitor atrial cardiomyopathy 125
The burden of atrial fibrillation in patients with preserved or mildly reduced heart failure: a call to action for detecting atrial fibrillation and improving outcome 122
Mobile health technology in atrial fibrillation 122
Screening for atrial fibrillation: different approaches targeted to reduce ischemic stroke 120
The challenge to improve knowledge on the interplay between subclinical atrial fibrillation, atrial cardiomyopathy, and atrial remodeling 120
Cardiovascular-kidney-metabolic domains and impact on antithrombotic treatment, integrated care and clinical outcomes in patients with atrial fibrillation: results from a prospective European registry 119
Remote monitoring of cardiac implantable electronic devices: from data to clinical actions 117
Procedural complications in patients undergoing catheter ablation for atrial fibrillation: Let's talk about sex 117
Multimorbidity in atrial fibrillation: A call for integrated patient-centered care 114
Letter by Imberti et al Regarding Article, "DREAM-ICD-II Study" 112
Effectiveness of atrial fibrillation ablation in heart failure across the entire spectrum of left ventricular ejection fraction 112
Updating a simple clinical score predicting incident atrial fibrillation: The C2HEST score or more (mC2HEST)? 112
Atrial fibrillation and female sex: use of oral anticoagulants in a large European cohort and residual risk of thromboembolism and stroke 111
Mobile/wearable digital devices for care of active cancer patients: a survey from the ESC Council of Cardio-Oncology 109
Atrial fibrillation screening: The importance of the patient perspective 108
Totale 18.617
Salva come PNG Salva come JPEG
Categoria #
all - tutte 91.988
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 91.988
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022501 0 0 0 0 25 43 18 38 68 42 126 141
2022/2023835 88 92 81 50 64 110 29 90 94 19 73 45
2023/20241.088 18 55 67 110 240 141 88 132 18 37 57 125
2024/20254.367 74 58 264 230 616 564 407 263 420 285 633 553
2025/20269.430 679 430 805 1.129 975 476 1.306 537 1.128 787 667 511
2026/20273.632 516 595 744 1.469 308 0 0 0 0 0 0 0
Totale 20.597